select a format

Single User License
USD 1995 INR 130553
Site License
USD 3990 INR 261106
Corporate User License
USD 5985 INR 391658

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-UK

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-UK


  • Products Id :- GDHC0053CHR
  • |
  • Pages: 253
  • |
  • March 2016
  • |
  • |
  Request for Sample Report

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-UK

Summary

GlobalData, the industry analysis specialist, has released its new report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-UK". The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2014, the UK`s population was approximately 64.2 million. The major factors contributing to the growth in the population are increase in net migration and decrease in death rate. The UK policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in the UK was estimated at USD 28.8 billion in 2015 and is expected to reach approximately USD 43.2 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 8.4%. The medical devices market size was approximately USD 14.4 billion in 2015 and is expected to reach approximately USD 17.9 billion by 2020 with a projected CAGR of 4.5%.

The positive trends in the UK healthcare market can be attributed primarily to-

Increasing elderly population

Universal healthcare insurance

High degree of access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes-

Overview of the pharmaceutical and medical devices market of the UK including the market size, market segmentation, key drivers and barriers.

Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Novartis, Roche and Merck. The key players covered for the medical devices market are Essilor International, GlaxoSmithKline, DePuy Companies, Johnson & Johnson and B.Braun.

Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices.

A detailed analysis of the political and economic environment of the UK including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.

An overview of the opportunities and challenges for growth that exist in the healthcare market of the UK.

Reasons To Buy

The report on the UK comprehensively covers both the pharmaceutical and the medical devices markets of the UK. The report will enhance your decision making capability. It will allow you to-

Develop business strategies by understanding the trends shaping and driving the healthcare market of the UK.

Drive revenue by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the the UK healthcare market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the various competitors.

Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidations, investments and strategic partnerships.

Identify, understand and capitalize on the opportunities and challenges in the healthcare market of the UK.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

1 Table of Contents

1 Table of Contents 6

1.1 List of Tables 9

1.2 List of Figures 13

2 Introduction 18

2.1 GlobalData Report Guidance 18

3 Overview of the Pharmaceutical and Medical Device Markets 19

3.1 Pharmaceutical Market 19

3.1.1 Market Overview 19

3.1.2 Pharmaceutical Exports and Imports 21

3.1.3 Supply Channels 22

3.1.4 Market Segments 24

3.1.5 Major Therapeutic Areas 26

3.1.6 Major Companies 32

3.2 Medical Device Market 76

3.2.1 Market Overview 76

3.2.2 Overview of Top Five Segments 78

3.2.3 Diagnostic market 89

3.2.4 Major Players 92

3.3 Market Drivers and Barriers 122

3.3.1 Drivers 122

3.3.2 Barriers 123

4 Market Access 125

4.1 Reimbursement and Payer Landscape 125

4.1.1 Overview of Healthcare System 125

4.1.2 Reimbursement Process 129

4.1.3 Overview of Insurance Providers 131

4.1.4 Patient Share in Healthcare Spending 133

4.1.5 Drug Price Change 134

4.1.6 Pricing Policies 135

4.2 Regulatory Landscape 136

4.2.1 Overview of Regulatory Agencies 136

4.2.2 Market Authorization Procedure for Pharmaceutical Products 138

4.2.3 New Medical Device Approval Process 149

4.2.4 Licensing Process for Pharmaceutical Manufacturing 156

4.2.5 Intellectual Property Rights 157

4.2.6 Clinical Trial Regulations 159

4.2.7 Pharmaceutical Advertising Regulations 162

4.2.8 Pharmacy Regulations 163

4.2.9 Labeling and Packaging Regulations 164

5 Country Analysis 166

5.1 Political Environment 166

5.1.1 Political Structure 166

5.1.2 Analysis of the Current Political Environment 167

5.1.3 Healthcare Policy Initiatives 169

5.2 Economic Landscape 170

5.3 Economic Indicators 171

5.3.1 Gross Domestic Product 171

5.3.2 Gross National Income 175

5.3.3 Inflation 176

5.3.4 Currency Exchange Rate 179

5.3.5 Foreign Direct Investment 181

5.3.6 Foreign Exchange Reserves 182

5.3.7 Trade Balance 183

5.3.8 Government Structural Balance 185

5.3.9 General Government Gross Debt 186

5.3.10 External Debt 188

5.3.11 Major Industries 189

5.4 Demographics 190

5.4.1 Population 190

5.4.2 Education and Literacy 206

5.4.3 Employment 208

5.4.4 Disease Burden 209

5.5 Healthcare Infrastructure 211

5.5.1 Healthcare Facilities 211

5.5.2 Healthcare Parameters 213

5.5.3 Environmental Health 215

5.5.4 Healthcare Personnel 220

5.6 Healthcare Expenditure 223

5.6.1 Overview 223

5.6.2 Components of Healthcare Spending 224

5.6.3 Public and Private Sector Share 226

5.6.4 Spending in Pharmaceutical R&D 227

5.7 Trade Associations 229

5.7.1 Association of the British Pharmaceutical Industry (ABPI) 229

5.7.2 British In Vitro Diagnostics Association (BIVDA) 229

5.7.3 National Pharmacy Association (NPA) 229

5.7.4 Association of British Healthcare Industries (ABHI) 230

5.7.5 British Generic Manufacturers Association (BGMA) 230

5.8 Trade Fairs 230

6 Opportunities and Challenges 232

6.1 Opportunities 232

6.2 Challenges 233

7 Appendix 235

7.1 Abbreviations 235

7.2 Bibliography 239

7.3 Research Methodology 250

7.3.1 Coverage 250

7.3.2 Secondary Research 250

7.3.3 Forecasts 251

7.3.4 Expert Panel 251

7.4 Disclaimer 252

1.2 List of Figures

Figure 1: Pharmaceutical Market, UK, Revenue (USD bn), 2008-2015 20

Figure 2: Pharmaceutical Market, UK, Revenue (USD bn), 2016-2020 21

Figure 3: Pharmaceutical Market, UK, Revenue by Exports and Imports (USD bn), 2008-2015 22

Figure 4: Pharmaceutical Market, UK, Supply Channels, 2014 23

Figure 5: Pharmaceutical Market, UK, Generic Launch, 2013 24

Figure 6: Major Therapeutic Areas, UK, Prescribing Cost (USD bn), 2015 26

Figure 7: Pharmaceutical Market, UK, NHS Gross Expenditure on Neurological Issues (USD bn), 2008-2015 27

Figure 8: Pharmaceutical Market, UK, NHS Gross Expenditure on Endocrine System Issues (USD bn), 2008-2015 28

Figure 9: Pharmaceutical Market, UK, NHS Gross Expenditure on Respiratory System Issues (USD bn), 2008-2015 29

Figure 10: Pharmaceutical Market, UK, NHS Gross Expenditure on Cardiovascular System Issues (USD bn), 2008-2015 30

Figure 11: Pharmaceutical Market, UK, NHS Gross Expenditure on Nutrition and Blood Issues (USD bn), 2008-2015 31

Figure 12: Medical Device Market, UK, Revenue (USD bn), 2008-2015 77

Figure 13: Medical Device Market, UK, Revenue (USD bn), 2016-2020 78

Figure 14: Medical Device Market, UK, Revenue (USD bn), 2014 79

Figure 15: Medical Device Market, UK, Orthopedic Devices Market, Revenue (USD bn), 2008-2015 80

Figure 16: Medical Device Market, UK, Orthopedic Devices Market, Market Share (%), 2014 81

Figure 17: Medical Device Market, UK, Ophthalmic Devices, Market Revenue (USD bn), 2008-2015 82

Figure 18: Medical Device Market, UK, Ophthalmic Devices Market Share (%), 2012 83

Figure 19: Medical Device Market, UK, Wound Care Management Market, Revenue (USD bn), 2008-2015 84

Figure 20: Medical Device Market, UK, Wound Care Management, Market Share (%), 2012 85

Figure 21: Medical Device Market, UK, Cardiovascular Device Market, Revenue (USD bn), 2008-2015 86

Figure 22: Medical Device Market, UK, Cardiovascular Device Market, Share (%), 2012 87

Figure 23: Medical Device Market, UK, In-vitro Diagnostic Devices Market, Revenue (USD bn), 2008-2015 88

Figure 24: Medical Device Market, UK, In-vitro Diagnostic Devices Market, Share (%), 2012 89

Figure 25: Medical Device Market, UK, Diagnostic Market, Revenue (USD bn), 2008-2015 90

Figure 26: Medical Device Market, UK, Diagnostic Market, Revenue (USD bn), 2016-2020 91

Figure 27: Healthcare Market, UK, Drivers and Barriers, 2015 124

Figure 28: Healthcare System, UK, 2015 126

Figure 29: Healthcare Spending, UK, Out-of-pocket Expenditure (% of Private Expenditure on Health), 2008-2015 134

Figure 30: Market Access, UK, Drug Price Change (%), 2008-2015 135

Figure 31 Healthcare System, UK, MHRA Structure, 2015 137

Figure 32: Healthcare System, UK, National Procedure for Market Authorization, 2015 139

Figure 33: Healthcare System, EU, Centralized Procedure, Pre-Submission, 2015 140

Figure 34: Healthcare System, EU, Centralized Procedure, Marketing Authorization, Pre-Opinion Phase, 2015 142

Figure 35: Healthcare System, EU, Centralized Procedure, Marketing Authorization, Post-opinion Phase, 2015 144

Figure 36: Healthcare System, EU, Decentralized Procedure, 2015 146

Figure 37: Healthcare System, EU, Mutual Recognition Procedure, 2015 148

Figure 38: Healthcare System, EU, Conformity Assessment of Class I Medical Devices, 2013 153

Figure 39: Healthcare System, EU, Conformity Assessment of Class IIa Medical Devices, 2013 154

Figure 40: Healthcare System, EU, Conformity Assessment of Class IIb Medical Devices, 2013 155

Figure 41: Healthcare System, EU, Conformity Assessment of Class III Medical Devices, 2013 156

Figure 42: Healthcare System, UK, Patent Approval Process, 2015 158

Figure 43: Healthcare System, UK, Clinical Trial Regulation Process for Medicines, 2015 160

Figure 44: Healthcare System, UK, Clinical Trial Regulation Process for Medical Devices, 2013 161

Figure 45: Economic Indicators, UK, GDP per Capita (USD ), 2008-2015 172

Figure 46: Economic Indicators, UK, GDP per Capita (USD ), 2016-2020 173

Figure 47: Economic Indicators, UK, GDP Annual Growth (%), 2008-2015 174

Figure 48: Economic Indicators, UK, GDP Annual Growth (%), 2016-2020 175

Figure 49: Economic Indicators, UK, National Income (USD tn), 2008-2014 176

Figure 50: Economic Indicators, UK, Average Consumer Price Index, 2008-2015 177

Figure 51: Economic Indicators, UK, Average Consumer Price Index, 2016-2020 178

Figure 52: Economic Indicators, UK, Average Consumer Price Annual Change (%), 2008-2014 179

Figure 53: Economic Indicators, UK, Currency Exchange Rate (USD to ), 2008-2014 180

Figure 54: Economic Indicators, UK, FDI (USD bn), 2008-2014 181

Figure 55: Economic Indicators, UK, Foreign Exchange Reserves (USD bn), 2008-2014 182

Figure 56: Economic Indicators, UK, Imports of Goods and Services (USD bn), 2008-2014 183

Figure 57: Economic Indicators, UK, Exports of Goods and Services (USD bn), 2008-2014 184

Figure 58: Economic Indicators, UK, Government Structural Balance (USD bn), 2008-2014 185

Figure 59: Economic Indicators, UK, General Government Gross Debt (% of GDP), 2008-2015 186

Figure 60: Economic Indicators, UK, General Government Gross Debt (% of GDP), 2016-2020 187

Figure 61: Economic Indicators, UK, External Debt (USD tn), 2008-2014 188

Figure 62: Economic Indicators, UK, Major Industries, Gross Value Added (USD bn), 2013 189

Figure 63: Demographics, UK, Population (million), 2008-2015 191

Figure 64: Demographics, UK, Population (million), 2016-2020 192

Figure 65: Demographics, UK, Urban and Rural Population (%), 2008-2014 193

Figure 66: Demographics, UK, Population Distribution by Age Group (%), 2008-2015 194

Figure 67: Demographics, UK, Population Distribution by Age Group (%), 2016-2020 195

Figure 68: Demographics, UK, Births (per 1,000 Population), 2008-2014 196

Figure 69: Demographics, UK, Mortality (per 1,000 Population), 2008-2014 197

Figure 70: Demographics, UK, Major Causes of Mortality (%), 2014 198

Figure 71: Demographics, UK, Infant Mortality (per 1,000 Live Births), 2008-2014 200

Figure 72: Demographics, UK, Immunization Rate (%), 2013 201

Figure 73: Demographics, UK, Major Causes of Male Mortality (000), 2014 202

Figure 74: Demographics, UK, Major Causes of Female Mortality (000), 2014 203

Figure 75: Demographics, UK, Gender Ratio (M/F), 2008-2014 204

Figure 76: Demographics, UK, Life Expectancy at Birth (Years), 2008-2014 205

Figure 77: Demographics, UK, Gross Enrollment (%), 2008-2015 207

Figure 78: Demographics, UK, Unemployment Rate (%), 2008-2014 208

Figure 79: Demographics, UK Disease Burden, DALYs (per 100,000 population), 2013 210

Figure 80: Healthcare Infrastructure, UK, Beds by Type of Service, 2008-2014 211

Figure 81: Healthcare Infrastructure, UK, Diagnostic Equipment (Per Million Population), 2008-2014 212

Figure 82: Healthcare Infrastructure, UK, Hospital Beds (Per 1,000 Population), 2008-2014 213

Figure 83: Healthcare Infrastructure, UK, Doctors (per 1,000 population), 2008-2014 214

Figure 84: Healthcare Infrastructure, UK, CO2 emissions (million tons), 2008-2014 217

Figure 85: Healthcare Infrastructure, UK, CH4 emissions (million tons)2008-2014 218

Figure 86: Healthcare Infrastructure, UK, PM10 (g/m3), 2008-2014 219

Figure 87: Healthcare Infrastructure, UK, Nurses (Per 1,000 Population), 2008-2014 220

Figure 88: Healthcare Infrastructure, UK, Pharmacists (per 1,000 Population), 2008-2014 221

Figure 89: Healthcare Infrastructure, UK, Dentists (Per 1,000 Population), 2008-2014 222

Figure 90: Healthcare Expenditure, UK, Healthcare Expenditure (% of GDP), 2008-2014 224

Figure 91: Healthcare Expenditure , UK, Consumption Expenditure on Medical Goods and Services, Share (%), 2013 225

Figure 92: Healthcare Expenditure, UK, Public and Private Share of Healthcare Expenditure (%), 2008-2014 227

Figure 93: Healthcare Expenditure, UK, Pharmaceutical R&D Expenditure (USD bn), 2008-2014 228

Figure 94: Healthcare Market, UK, Opportunities and Challenges, 2015 234

1.1 List of Tables

Table 1: Pharmaceutical Market, UK, Revenue (USD bn), 2008-2015 20

Table 2: Pharmaceutical Market, UK, Revenue (USD bn), 2016-2020 21

Table 3: Pharmaceutical Market, UK, Revenue by Exports and Imports (USD bn), 2008-2015 22

Table 4: Major Therapeutic Areas, UK, Prescribing cost (USD bn) , 2015 26

Table 5: Pharmaceutical Market, UK, NHS Gross Expenditure on Neurological Issues (USD bn), 2008-2015 27

Table 6: Pharmaceutical Market, UK, NHS Gross Expenditure on Endocrine System Issues (USD bn), 2008-2015 28

Table 7: Pharmaceutical Market, UK, NHS Gross Expenditure on Respiratory System Problems (USD bn), 2008-2015 29

Table 8: Pharmaceutical Market, UK, NHS Gross Expenditure on Cardiovascular System Problems (USD bn), 2008-2015 30

Table 9: Pharmaceutical Market, UK, NHS Gross Expenditure on Nutrition and Blood Problems (USD bn), 2008-2015 31

Table 10: Pharmaceutical Market, Pfizer, Global, Major Products by Revenue (USD bn) and Annual Growth (%), Revenue, 2014 33

Table 11: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015 34

Table 12: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2014 42

Table 13: Pharmaceutical Market, GlaxoSmithKline, Global, Late-Stage Pipeline, 2015 43

Table 14: Pharmaceutical Market, Novartis, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2013 50

Table 15: Pharmaceutical Market, Novartis, Global, Planned Filings, 2016-2019 51

Table 16: Pharmaceutical Market, Roche, Global, Major Products, Revenue (USD m) and Annual Growth (%), 2013 60

Table 17: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2013 61

Table 18: Pharmaceutical Market, Merck, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2013 69

Table 19: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2014 70

Table 20: Medical Device Market, UK, Revenue (USD bn), 2008-2015 77

Table 21: Medical Device Market, UK, Revenue (USD bn), 2016-2020 78

Table 22: Medical Device Market, UK, Revenue (USD bn), 2014 79

Table 23: Medical Device Market, UK, Orthopedic Devices Market, Revenue (USD bn), 2008-2015 80

Table 24: Medical Device Market, UK, Orthopedic Devices Market, Market Share (%), 2014 81

Table 25: Medical Device Market, UK, Ophthalmic Devices, Market Revenue (USD bn), 2008-2015 82

Table 26: Medical Device Market, UK, Ophthalmic Devices, Market Share (%), 2014 83

Table 27: Medical Device Market, UK, Wound Care Management Market, Revenue (USD bn), 2008-2015 84

Table 28: Medical Device Market, UK, Wound Care Management, Market Share (%), 2012 85

Table 29: Medical Device Market, UK, Cardiovascular Device Market, Revenue (USD bn), 2008-2015 86

Table 30: Medical Device Market, UK, Cardiovascular Device Market, Market Share, 2012 87

Table 31: Medical Device Market, UK, In-vitro Diagnostic Devices Market, Revenue (USD bn), 2008-2015 88

Table 32: Medical Device Market, UK, In-vitro Diagnostic Devices Market, Share (%), 2012 89

Table 33: Medical Device Market, UK, Diagnostic Market, Revenue (USD bn), 2008-2015 90

Table 34: Medical Device Market, UK, Diagnostic Market, Revenue (USD bn), 2016-2020 91

Table 35: Medical Device Market, GlaxoSmithKline, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2014 109

Table 36: Healthcare Spending, UK, Out-of-pocket Expenditure (% of Private Expenditure on Health), 2008-2015 134

Table 37: Market Access, UK, Drug Price Change (%), 2008-2015 135

Table 38: Market Access, UK, Schedule of Patent Fees, 2015 158

Table 39: Market Access, UK, Schedule of Trademark Fees, 2015 159

Table 40: Market Access, UK, Clinical Trials Application Fees, 2015 160

Table 41: Market Access, UK, Clinical trials application fees, 2015 162

Table 42: Economic Indicators, UK, GDP per Capita (USD ), 2008-2015 172

Table 43: Economic Indicators, UK, GDP per Capita (USD ), 2016-2020 173

Table 44: Economic Indicators, UK, GDP Annual Growth (%), 2008-2015 174

Table 45: Economic Indicators, UK, GDP Annual Growth (%), 2016-2020 175

Table 46: Economic Indicators, UK, National Income (USD tn), 2008-2014 176

Table 47: Economic Indicators, UK, Average Consumer Price Index, 2008-2015 177

Table 48: Economic Indicators, UK Average Consumer Price Index, 2016-2020 178

Table 49: Economic Indicators, UK, Average Consumer Price Annual Change (%), 2008-2014 179

Table 50: Economic Indicators, UK, Currency Exchange Rate ( to USD ), 2008-2014 180

Table 51: Economic Indicators, UK, FDI (USD bn), 2008-2014 181

Table 52: Economic Indicators, UK, Foreign Exchange Reserves (USD bn), 2008-2014 182

Table 53: Economic Indicators, UK, Imports of Goods and Services (USD bn), 2008-2014 183

Table 54: Economic Indicators, UK, Exports of Goods and Services (USD bn), 2008-2014 184

Table 55: Economic Indicators, UK, Government Structural Balance (USD bn), 2008-2014 185

Table 56: Economic Indicators, UK, General Government Gross Debt (% of GDP), 2008-2015 186

Table 57: Economic Indicators, UK, General Government Gross Debt (% of GDP), 2016-2020 187

Table 58: Economic Indicators, UK, External Debt (USD tr), 2008-2014 188

Table 59: Economic Indicators, UK, Major Industries, National Income by Industry (USD bn), 2013 190

Table 60: Demographics, UK, Population (million), 2008-2014 191

Table 61: Demographics, UK, Population Forecast (million), 2016-2020 192

Table 62: Demographics, UK, Urban and Rural Population (%), 2008-2014 193

Table 63: Demographics, UK, Population Distribution by Age Group (%), 2008-2015 194

Table 64: Demographics, UK, Population Distribution by Age Group (%), 2016-2020 195

Table 65: Demographics, UK, Births (per 1,000 Population), 2008-2014 196

Table 66: Demographics, UK, Mortality (per 1,000 Population), 2008-2014 197

Table 67: Demographics, UK, Major Causes of Mortality (%), 2014 199

Table 68: Demographics, UK, Infant Mortality (per 1,000 Live Births), 2008-2014 200

Table 69: Demographics, UK, Immunization Rate (%), 2013 201

Table 70: Demographics, UK, Major Causes of Male Mortality (000), 2014 202

Table 71: Demographics, UK, Major Causes of Female Mortality (000), 2014 203

Table 72: Demographics, UK, Gender Ratio (M/F), 2008-2014 204

Table 73: Demographics, UK, Life Expectancy at Birth (Years), 2008-2014 205

Table 74: Demographics, UK, Gross Enrollment (%), 2008-2015 207

Table 75: Demographics, UK, Unemployment Rate (%), 2008-2014 208

Table 76: Demographics, UK, Disease Burden, DALYs (per 100,000 population), 2013 210

Table 77: Healthcare Infrastructure, UK, Beds by Type of Service, 2008-2014 211

Table 78: Healthcare Infrastructure, UK, Diagnostic Equipment (Per Million Population), 2008-2014 212

Table 79: Healthcare Infrastructure, UK, Hospital Beds (per 1,000 Population), 2008-2014 214

Table 80: Healthcare Infrastructure, UK, Doctors (per 1,000 population), 2008-2014 215

Table 81: Healthcare Infrastructure, UK, CO2 emissions (million), 2008-2014 217

Table 82: Healthcare Infrastructure, UK, CH4 emissions (million tons), 2008-2014 218

Table 83: Healthcare Infrastructure, UK, PM10 (g/m3), 2008-2014 219

Table 84: Healthcare Infrastructure, UK, Nurses (Per 1,000 Population), 2008-2014 220

Table 85: Healthcare Infrastructure, UK, Pharmacists (per 1,000 Population), 2008-2014 221

Table 86: Healthcare Infrastructure, UK, Dentists (Per 1,000 Population), 2008-2014 222

Table 87: Healthcare Expenditure, UK, Healthcare Expenditure (% of GDP), 2008-2014 224

Table 88: Healthcare Expenditure , UK, Consumption Expenditure on Medical Goods and Services, Share (%), 2013 226

Table 89: Healthcare Expenditure, UK, Public and Private Share of Healthcare Expenditure (%), 2008-2014 227

Table 90: Healthcare Expenditure, UK, Pharmaceutical R&D Expenditure (USD bn), 2008-2014 229

Table 91: Major Healthcare Trade Fairs, UK, 2016 231

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pharmaceutical and medical device market, SWOT analysis, regulatory landscape, reimbursement landscape,Country analysis, drivers and barriers, opportunities and challenges


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com